Skip to content
The Policy VaultThe Policy Vault

Tygacil — CareFirst (Caremark)

Complicated skin and skin structure infections caused by susceptible isolates of Escherichia coli, Enterococcus faecalis (vancomycin-susceptible isolates), Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus agalactiae, Streptococcus anginosus group (S. anginosus, S. intermedius, S. constellatus), Streptococcus pyogenes, Enterobacter cloacae, Klebsiella pneumoniae, and Bacteroides fragilis

Initial criteria

  • Patient age ≥ 18 years
  • Used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria
  • Appropriate cultures obtained before therapy to identify causative organism and confirm susceptibility
  • Not indicated for diabetic foot infections or hospital-acquired or ventilator-associated pneumonia
  • May be initiated empirically prior to culture results if serious infection suspected